First-in-human use of recombinant IL-7 to potentiate antigen-specific T cell therapy: a single patient case study
Clinical trials of adoptive cellular therapy demonstrate that a key characteristic associated with durable responses is in vivo expansion and persistence of transferred T cells. Strategies to develop a less differentiated, stem/memory population in th…